Core Viewpoint - Zhendemedical (603301) has experienced a decline in stock price, closing at 68.77 yuan, down 3.06% from the previous week, with a current market capitalization of 18.282 billion yuan [1] Group 1: Stock Performance - As of January 30, 2026, Zhendemedical's stock closed at 68.77 yuan, down from 70.94 yuan the previous week, marking a decrease of 3.06% [1] - The stock reached a weekly high of 72.5 yuan on January 26 and a low of 66.17 yuan on January 30 [1] - The company's current total market capitalization is 18.282 billion yuan, ranking 13th out of 127 in the medical device sector and 1167th out of 5184 in the A-share market [1] Group 2: Company Announcements - Zhendemedical plans to revise its second employee stock ownership plan (draft) and management measures, specifying that unvested shares will be repurchased and canceled [2] - The company intends to repurchase 1,829,868 shares from the second employee stock ownership plan at a price of 22.17 yuan per share [2][3] - The total number of shares will decrease from 265,835,535 to 263,876,225 shares, with the corresponding amendments to the company's articles of association and registration changes [2][3]
每周股票复盘:振德医疗(603301)拟注销195.9万股股份